http://purl.org/np/RAh1j-oIkzGzdqGsjWLgBQ_nH08TK-WAaSIdOc_PmsF2s
.trig | .trig.txt | .jelly | .jelly.txt
@prefix this: <http://purl.org/np/RAh1j-oIkzGzdqGsjWLgBQ_nH08TK-WAaSIdOc_PmsF2s> .
@prefix sub: <http://purl.org/np/RAh1j-oIkzGzdqGsjWLgBQ_nH08TK-WAaSIdOc_PmsF2s#> .
@prefix np: <http://www.nanopub.org/nschema#> .
@prefix pav: <http://purl.org/pav/> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix infores: <https://w3id.org/biolink/infores/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix umls: <http://identifiers.org/umls/> .
@prefix orcid: <https://orcid.org/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix biolink: <https://w3id.org/biolink/vocab/> .
@prefix prov: <http://www.w3.org/ns/prov#> .
@prefix npx: <http://purl.org/nanopub/x/> .
sub:Head {
this: a np:Nanopublication;
np:hasAssertion sub:assertion;
np:hasProvenance sub:provenance;
np:hasPublicationInfo sub:pubInfo .
}
sub:assertion {
<http://identifiers.org/pubchem.compound/117761397> a biolink:ChemicalEntity;
rdfs:label "CAMZYOS";
biolink:category biolink:ChemicalEntity .
umls:C0263630 a biolink:DiseaseOrPhenotypicFeature;
rdfs:label "hypertrophic";
biolink:category biolink:DiseaseOrPhenotypicFeature .
<http://purl.obolibrary.org/obo/CHEBI_8735> a biolink:ChemicalEntity;
rdfs:label "™";
biolink:category biolink:ChemicalEntity .
<http://purl.obolibrary.org/obo/MONDO_0005045> a biolink:DiseaseOrPhenotypicFeature;
rdfs:label "HCM";
biolink:category biolink:DiseaseOrPhenotypicFeature .
<http://purl.obolibrary.org/obo/OMIM_MTHU037025> a biolink:DiseaseOrPhenotypicFeature;
rdfs:label "obstructive hypertrophic cardiomyopathy";
biolink:category biolink:DiseaseOrPhenotypicFeature .
sub:_1 a biolink:Association;
rdf:object <file:///app/hypertrophrophyopathy>;
rdf:predicate biolink:treats;
rdf:subject <http://identifiers.org/pubchem.compound/117761397>;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> .
sub:_2 a biolink:Association;
rdf:object <file:///app/hypertrophrophyopathy>;
rdf:predicate biolink:treats;
rdf:subject <http://identifiers.org/pubchem.compound/117761397>;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> .
sub:_3 a biolink:Association;
rdf:object <http://purl.obolibrary.org/obo/MONDO_0005045>;
rdf:predicate biolink:treats;
rdf:subject <http://identifiers.org/pubchem.compound/117761397>;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> .
sub:_4 a biolink:Association;
rdf:object <http://purl.obolibrary.org/obo/OMIM_MTHU037025>;
rdf:predicate biolink:treats;
rdf:subject <http://identifiers.org/pubchem.compound/117761397>;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> .
sub:_5 a biolink:Association;
rdf:object umls:C0263630;
rdf:predicate biolink:treats;
rdf:subject <http://identifiers.org/pubchem.compound/117761397>;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> .
sub:_6 a biolink:Association;
rdf:object umls:C0263630;
rdf:predicate biolink:treats;
rdf:subject <http://identifiers.org/pubchem.compound/117761397>;
biolink:aggregator_knowledge_source infores:knowledge-collaboratory;
biolink:category biolink:Association;
biolink:publications <https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b60c9c82-e5c7-4e05-98c7-5bbba4af04b2> .
}
sub:provenance {
sub:assertion prov:generatedAtTime "2022-10-11T09:30:02.005341"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-3668-2627;
prov:wasQuotedFrom "CAMZYOS™ is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyopathy (HCM) to improve functional capacity and symptoms. CAMYOS was indicated for adults with. symptomatic. New York. Heart Association class II and III obstructive. hypertrophic. hypertrophrophyopathy." .
biolink: pav:version "2.3.0" .
}
sub:pubInfo {
sub:sig npx:hasAlgorithm "RSA";
npx:hasPublicKey "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB";
npx:hasSignature "fegq/Asx9Gi6GG7pCrJBqW0MC9cTCOH4fT5NT7jDSuFyvzRs6XKaK9WC9QZVmyJ1XQyW5/0QnJmFVAcENdP1GnPe5HKQ/tEOS6+scC4oE6gzsV8GxPWKbSJPAtjNJMlKsB3M6CsIl7TVvWZ4MiDzWxX5dfUc/llMouUkoTozTdkbSFzp17ZrFcl0q1HVaQ4ndh+pDWZz/PD4rKbAOZNidWgvfzYwcJoVUJQ52Lxrg8UQwXJmyU5UMTRoj44uEVkn3u9wieW+Su4oeRIC/cN22grfD0Km6kGEsz3Anmw4MamF9t/qo3kmJgt0RVpPcZKKBjc2a/l3K7ffBd/I8A6X0A==";
npx:hasSignatureTarget this: .
this: prov:generatedAtTime "2022-10-11T09:30:02.005341"^^xsd:dateTime;
prov:wasAttributedTo orcid:0000-0002-3668-2627 .
}